Certara is a global leader in biosimulation and model-informed drug development (MIDD). The company provides software, technology-enabled services, and regulatory science expertise to help biopharmaceutical companies accelerate the development of safe and effective therapies. Certara's solutions span the entire drug development lifecycle, from discovery through preclinical and clinical development to regulatory submission and market access, aiming to optimize dosing, predict drug performance, and improve clinical trial design.
Serves as the central hub for executive leadership, global strategy, corporate finance, legal, and administrative functions.
Located within a modern corporate office park, offering contemporary facilities designed to support collaboration and innovation.
The headquarters fosters a professional, science-driven, and collaborative work environment, reflecting its focus on cutting-edge biosimulation and pharmaceutical consulting.
Strategically positioned in the New Jersey life sciences corridor, facilitating close interaction with numerous pharmaceutical clients, partners, and talent pools.
Certara operates globally with offices and experts across North America, Europe, and Asia-Pacific. This worldwide network supports key functions including software R&D, scientific consulting (pharmacometrics, PBPK, regulatory science, market access), client support, training, sales, and business development, enabling tailored solutions for the international biopharmaceutical industry.
100 Overlook Center, Suite 101
Princeton
NJ
USA
Address: Level 2, Block B, The Portergate, Ecclesall Road, Sheffield, S11 8NX, UK
Key center for R&D, scientific support, and training services for the European market and global clients utilizing the Simcyp platform.
Address: 1000 De La Gauchetière Street West, Suite 1610, Montreal, QC H3B 4W5, Canada
Supports North American and global clients with software solutions, development, and expert consulting in pharmacometrics.
Address: PMO Nihonbashi Kayabacho, 1-6-14 Nihonbashi Kayabacho, Chuo-ku, Tokyo 103-0025, Japan
Serves as a key base for engaging with clients and regulatory agencies in the APAC region, facilitating market access and drug development.
Address: 7733 Forsyth Blvd, Suite 1600, St. Louis, MO 63105, USA
Supports clients globally in demonstrating product value and securing optimal market access and reimbursement.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Certara' leadership includes:
Certara has been backed by several prominent investors over the years, including:
Over the past 12 months, Certara has seen stability in its core C-suite leadership team, with activity primarily focused on Board appointments rather than major executive hires or departures. Two new members joined the Board of Directors.
Discover the tools Certara uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Certara primarily utilizes the first name dot last name format for employee emails.
[first].[last]@certara.com
Format
william.feehery@certara.com
Example
90%
Success rate
Business Wire • May 8, 2024
Certara announced its financial results for the first quarter ended March 31, 2024, reporting revenue and discussing business performance and outlook....more
Certara Website / Press Release • May 20, 2024
Certara highlighted its latest innovations, including the integration of Artificial Intelligence (AI) with biosimulation techniques to further accelerate drug development, presented at a recent scientific or industry event....more
Certara Website / Press Release • March 27, 2024
Certara announced its significant presence and multiple presentations at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting, showcasing advancements in model-informed drug development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Certara, are just a search away.